If an ACPA positive individual is identified who has these factors (e.g. dual RF isotype positivity, SE positivity, potentially high-positive ACPA), it may aid in counseling them as to their overall risk and potential timing of development of future IA/RA as well as referral to clinical rheumatologic care (15). This evidence concerns the gene PRTN3 and rheumatoid arthritis.